CO4940408A1 - Composicion de aerosol farmaceutico - Google Patents
Composicion de aerosol farmaceuticoInfo
- Publication number
- CO4940408A1 CO4940408A1 CO98033837A CO98033837A CO4940408A1 CO 4940408 A1 CO4940408 A1 CO 4940408A1 CO 98033837 A CO98033837 A CO 98033837A CO 98033837 A CO98033837 A CO 98033837A CO 4940408 A1 CO4940408 A1 CO 4940408A1
- Authority
- CO
- Colombia
- Prior art keywords
- aerosol composition
- pharmaceutical aerosol
- inhaler
- composition
- aerosol
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000008249 pharmaceutical aerosol Substances 0.000 title 1
- 239000000443 aerosol Substances 0.000 abstract 2
- 150000005828 hydrofluoroalkanes Chemical class 0.000 abstract 2
- BLUGYPPOFIHFJS-UUFHNPECSA-N (2s)-n-[(2s)-1-[[(3r,4s,5s)-3-methoxy-1-[(2s)-2-[(1r,2r)-1-methoxy-2-methyl-3-oxo-3-[[(1s)-2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-1-yl]-5-methyl-1-oxoheptan-4-yl]-methylamino]-3-methyl-1-oxobutan-2-yl]-3-methyl-2-(methylamino)butanamid Chemical compound CN[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H]([C@@H](C)CC)[C@H](OC)CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C=1SC=CN=1)CC1=CC=CC=C1 BLUGYPPOFIHFJS-UUFHNPECSA-N 0.000 abstract 1
- 208000007934 ACTH-independent macronodular adrenal hyperplasia Diseases 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 239000011149 active material Substances 0.000 abstract 1
- 239000006184 cosolvent Substances 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 239000003380 propellant Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9712434A GB2326334A (en) | 1997-06-13 | 1997-06-13 | Pharmaceutical aerosol compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
CO4940408A1 true CO4940408A1 (es) | 2000-07-24 |
Family
ID=10814179
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO98033837A CO4940408A1 (es) | 1997-06-13 | 1998-06-12 | Composicion de aerosol farmaceutico |
Country Status (44)
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9616237D0 (en) | 1996-08-01 | 1996-09-11 | Norton Healthcare Ltd | Aerosol formulations |
US20010031244A1 (en) | 1997-06-13 | 2001-10-18 | Chiesi Farmaceutici S.P.A. | Pharmaceutical aerosol composition |
DZ2947A1 (fr) | 1998-11-25 | 2004-03-15 | Chiesi Farma Spa | Inhalateur à compteur de dose sous pression. |
IT1303788B1 (it) * | 1998-11-25 | 2001-02-23 | Chiesi Farma Spa | Formulazioni di aerosol medicinali. |
IT1313553B1 (it) | 1999-07-23 | 2002-09-09 | Chiesi Farma Spa | Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione. |
JP2003509359A (ja) | 1999-09-11 | 2003-03-11 | グラクソ グループ リミテッド | プロピオン酸フルチカゾンの医薬製剤 |
AU1534501A (en) * | 1999-11-23 | 2001-06-04 | Glaxo Group Limited | Pharmaceutical formulations of salmeterol |
JP2003518484A (ja) * | 1999-12-24 | 2003-06-10 | グラクソ グループ リミテッド | サルメテロールおよびプロピオン酸フルチカゾンの医薬用エアゾル製剤 |
IT1317846B1 (it) * | 2000-02-22 | 2003-07-15 | Chiesi Farma Spa | Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva. |
IT1318514B1 (it) * | 2000-05-12 | 2003-08-27 | Chiesi Farma Spa | Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari. |
JP5392880B2 (ja) * | 2000-05-22 | 2014-01-22 | キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ | 加圧式定量吸入器のための安定な製薬学的溶液製剤 |
WO2002072067A2 (en) * | 2001-03-12 | 2002-09-19 | Glaxo Group Limited | Pharmaceutical aerosol formulation |
PT1273292E (pt) | 2001-07-02 | 2004-10-29 | Chiesi Farma Spa | Formulacao optimizada de tobramicina para aerossolizacao |
SI3536344T1 (sl) | 2002-03-01 | 2020-06-30 | Chiesi Farmaceutici S.P.A. | Superfina formulacija formoterola |
EP1340492A1 (en) * | 2002-03-01 | 2003-09-03 | CHIESI FARMACEUTICI S.p.A. | Aerosol formulations for pulmonary administration of medicaments having systemic effects |
EP1340503A1 (en) * | 2002-03-01 | 2003-09-03 | CHIESI FARMACEUTICI S.p.A. | Solution aerosol formulation containing esters of 3, 17-dihydroxy oestratriene derivates for pulmonary delivery |
DE10214263A1 (de) * | 2002-03-28 | 2003-10-16 | Boehringer Ingelheim Pharma | HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum |
ES2275778T3 (es) * | 2002-06-06 | 2007-06-16 | Chiesi Farmaceutici S.P.A. | Solubilizacion de farmacos en propulsores de hfa mediante emulsiones. |
AU2003293528A1 (en) * | 2003-02-04 | 2004-09-06 | Chrysalis Technologies Incorporated | Perfluorocarbon and hydrofluorocarbon formulations and methods of making and using same |
EP1608336B1 (en) * | 2003-03-20 | 2008-03-26 | Boehringer Ingelheim Pharmaceuticals Inc. | Formulation for a metered dose inhaler using hydro-fluoro-alkanes as propellants |
EP1915985A1 (en) * | 2003-03-20 | 2008-04-30 | Boehringer Ingelheim Pharmaceuticals Inc. | Formulation for a Metered Dose Inhaler Using Hydro-Fluoro-Alkanes as Propellants |
EP1595531A1 (en) | 2004-05-13 | 2005-11-16 | CHIESI FARMACEUTICI S.p.A. | Stable pharmaceutical solution formulations for pressurized metered dose inhalers |
AU2005259523B2 (en) | 2004-07-02 | 2011-06-09 | Boehringer Ingelheim International Gmbh | Aerosol suspension formulations containing TG 227 ea or TG 134 a as a propellant |
DE102006017320A1 (de) | 2006-04-11 | 2007-10-18 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel |
GB0621707D0 (en) * | 2006-10-31 | 2006-12-13 | Univ London Pharmacy | Formulations for delivery via pressurised metered dose inhalers |
GB0712454D0 (en) | 2007-06-27 | 2007-08-08 | Generics Uk Ltd | Pharmaceutical compositions |
WO2009061273A1 (en) * | 2007-11-07 | 2009-05-14 | Astrazeneca Ab | Dry powder formulations comprising ascorbic acid derivates |
WO2012032010A1 (en) * | 2010-09-06 | 2012-03-15 | Chiesi Farmaceutici S.P.A. | Metered-dose inhaler and method of using the same |
JP5409594B2 (ja) * | 2010-12-22 | 2014-02-05 | キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ | 加圧式定量吸入器のための安定な製薬学的溶液製剤 |
JP6335798B2 (ja) | 2012-02-28 | 2018-05-30 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規噴射剤含有チオトロピウム製剤 |
RU2504402C1 (ru) * | 2012-11-20 | 2014-01-20 | Шолекс Девелопмент Гмбх | Ингаляционный состав в форме аэрозоля для лечения бронхиальной астмы и хронической обструктивной болезни легких |
GB201402513D0 (en) | 2014-02-13 | 2014-04-02 | Cardiff Scintigraphics Ltd | Pressurised metered dose inhalers and method of manufacture |
EP3174522A1 (en) | 2014-07-29 | 2017-06-07 | 3M Innovative Properties Company | Method of preparing a pharmaceutical composition |
WO2017167737A1 (en) | 2016-03-31 | 2017-10-05 | Chiesi Farmaceutici S.P.A. | Aerosol inhalation device |
EP3610877A1 (en) * | 2016-09-19 | 2020-02-19 | Mexichem Fluor S.A. de C.V. | Pharmaceutical composition |
WO2025039045A1 (en) * | 2023-08-23 | 2025-02-27 | Inhaler Supplies Pty Ltd | Inhalable formulation for volatile actives |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4869899A (en) † | 1986-03-10 | 1989-09-26 | Walter Burghart | Pharmaceutical preparation and process for producing the same |
EP0259383B1 (de) † | 1986-03-10 | 1991-01-23 | Kurt Dr. Burghart | Pharmazeutikum sowie verfahren zu seiner herstellung |
US4899874A (en) † | 1988-04-26 | 1990-02-13 | Rehrig-Pacific Company, Inc. | Stackable low depth bottle case |
GB8828477D0 (en) * | 1988-12-06 | 1989-01-05 | Riker Laboratories Inc | Medical aerosol formulations |
US5225183A (en) † | 1988-12-06 | 1993-07-06 | Riker Laboratories, Inc. | Medicinal aerosol formulations |
DE3905726A1 (de) * | 1989-02-24 | 1990-08-30 | Hoechst Ag | Druckgaspackung und treibmittel fuer aerosole |
ES2064160T3 (es) † | 1990-10-18 | 1995-01-16 | Minnesota Mining & Mfg | Formulacion de aerosol que comprende 17,21-dipropionato de beclometasona. |
GB9024365D0 (en) * | 1990-11-09 | 1991-01-02 | Glaxo Group Ltd | Medicaments |
EP0504112A3 (en) * | 1991-03-14 | 1993-04-21 | Ciba-Geigy Ag | Pharmaceutical aerosol formulations |
ZA924163B (en) † | 1991-06-10 | 1993-02-24 | Schering Corp | Non-chlorofluorocarbon aerosol formulations |
DK0588897T3 (da) * | 1991-06-10 | 1996-03-18 | Schering Corp | Aerosolformuleringer, der i det væsentlige er fri for chlorfluorcarbonforbindelser |
DE4123668A1 (de) * | 1991-07-17 | 1993-01-21 | Rovema Gmbh | Verfahren und vorrichtung zur zufuehrung von folienmaterial zu einer intermittierend arbeitenden schlauchbeutelmaschine |
DE4123663A1 (de) * | 1991-07-17 | 1993-01-21 | Schwabe Willmar Gmbh & Co | Aerosol-zubereitung und verwendung eines treibmittels dafuer |
ATE128350T1 (de) * | 1991-12-12 | 1995-10-15 | Glaxo Group Ltd | Pharmazeutische aerosolformulierung. |
DK1086688T3 (da) * | 1991-12-18 | 2004-08-16 | Minnesota Mining & Mfg | Aerosolformuleringer til suspensioner |
DE69324161T2 (de) * | 1992-12-09 | 1999-10-28 | Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield | Stabilisierte medizinische aerosollösungen |
US5502076A (en) * | 1994-03-08 | 1996-03-26 | Hoffmann-La Roche Inc. | Dispersing agents for use with hydrofluoroalkane propellants |
US5508023A (en) * | 1994-04-11 | 1996-04-16 | The Center For Innovative Technology | Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant |
US5534242A (en) † | 1994-05-02 | 1996-07-09 | Henry; Richard A. | Lidocaine-vasoconstrictor aerosol preparation |
WO1995031182A1 (en) † | 1994-05-13 | 1995-11-23 | Aradigm Corporation | Narcotic containing aerosol formulation |
US5653961A (en) † | 1995-03-31 | 1997-08-05 | Minnesota Mining And Manufacturing Company | Butixocort aerosol formulations in hydrofluorocarbon propellant |
US5635161A (en) † | 1995-06-07 | 1997-06-03 | Abbott Laboratories | Aerosol drug formulations containing vegetable oils |
GB9517998D0 (en) † | 1995-09-04 | 1995-11-08 | Bioglan Lab Ltd | Compositions and device for their administration |
JP2000514085A (ja) * | 1996-07-08 | 2000-10-24 | ローヌ―プーラン・ロウラー・リミテッド | 医薬シクロスポリンaエーロゾル溶液処方物 |
CA2273835A1 (en) † | 1996-12-04 | 1998-06-11 | Bioglan Ireland (R & D) Limited | Pharmaceutical compositions and devices for their administration |
AU718967B2 (en) † | 1997-02-05 | 2000-05-04 | Jagotec Ag | Medical aerosol formulations |
-
1997
- 1997-06-13 GB GB9712434A patent/GB2326334A/en not_active Withdrawn
- 1997-07-28 IT IT97MI001798A patent/IT1293803B1/it active IP Right Grant
-
1998
- 1998-06-10 AT AT98937474T patent/ATE222751T1/de active
- 1998-06-10 EP EP98937474A patent/EP0920302B2/en not_active Expired - Lifetime
- 1998-06-10 JP JP50162299A patent/JP4380802B2/ja not_active Expired - Lifetime
- 1998-06-10 PL PL98331531A patent/PL193721B1/pl unknown
- 1998-06-10 DE DE69807420T patent/DE69807420T3/de not_active Expired - Lifetime
- 1998-06-10 CA CA002263445A patent/CA2263445C/en not_active Expired - Lifetime
- 1998-06-10 DK DK98937474T patent/DK0920302T4/da active
- 1998-06-10 RS YUP-69/99A patent/RS51274B/sr unknown
- 1998-06-10 ID IDW990051A patent/ID21491A/id unknown
- 1998-06-10 KR KR1019997001274A patent/KR100546239B1/ko not_active Expired - Lifetime
- 1998-06-10 EP EP02007496A patent/EP1219293A3/en not_active Withdrawn
- 1998-06-10 CN CNB988008300A patent/CN1138532C/zh not_active Expired - Lifetime
- 1998-06-10 HU HU0001339A patent/HU228487B1/hu unknown
- 1998-06-10 PT PT98937474T patent/PT920302E/pt unknown
- 1998-06-10 TR TR1999/00288T patent/TR199900288T1/xx unknown
- 1998-06-10 NZ NZ334149A patent/NZ334149A/xx not_active IP Right Cessation
- 1998-06-10 ES ES98937474T patent/ES2182351T5/es not_active Expired - Lifetime
- 1998-06-10 IL IL12848498A patent/IL128484A/en not_active IP Right Cessation
- 1998-06-10 BR BRPI9805993-9A patent/BR9805993B1/pt active IP Right Grant
- 1998-06-10 SI SI9830245T patent/SI0920302T2/sl unknown
- 1998-06-10 ME MEP-2008-440A patent/ME00333B/me unknown
- 1998-06-10 CZ CZ1999462A patent/CZ295521B6/cs not_active IP Right Cessation
- 1998-06-10 SK SK176-99A patent/SK284430B6/sk not_active IP Right Cessation
- 1998-06-10 ME MEP-440/08A patent/MEP44008A/xx unknown
- 1998-06-10 AU AU86262/98A patent/AU729966B2/en not_active Expired
- 1998-06-10 EE EEP199900055A patent/EE03664B1/xx unknown
- 1998-06-10 WO PCT/EP1998/003533 patent/WO1998056349A1/en active IP Right Grant
- 1998-06-10 EA EA199900201A patent/EA001259B1/ru not_active IP Right Cessation
- 1998-06-10 GE GEAP19984709A patent/GEP20012462B/en unknown
- 1998-06-12 MA MA25113A patent/MA26507A1/fr unknown
- 1998-06-12 CO CO98033837A patent/CO4940408A1/es unknown
- 1998-06-12 MY MYPI98002641A patent/MY119074A/en unknown
- 1998-06-12 HR HR980317A patent/HRP980317B1/xx not_active IP Right Cessation
- 1998-06-12 TN TNTNSN98087A patent/TNSN98087A1/fr unknown
- 1998-06-12 AR ARP980102805A patent/AR012977A1/es not_active Application Discontinuation
- 1998-06-12 ZA ZA985136A patent/ZA985136B/xx unknown
- 1998-06-13 DZ DZ980126A patent/DZ2516A1/xx active
- 1998-06-18 IN IN1604DE1998 patent/IN189317B/en unknown
- 1998-07-08 TW TW087111036A patent/TW555570B/zh not_active IP Right Cessation
- 1998-10-06 UA UA99020906A patent/UA70289C2/uk unknown
- 1998-11-25 SA SA98190821A patent/SA98190821B1/ar unknown
-
1999
- 1999-02-09 NO NO19990594A patent/NO327775B1/no not_active IP Right Cessation
- 1999-02-11 IS IS4974A patent/IS2435B/is unknown
- 1999-03-01 BG BG103221A patent/BG63906B1/bg unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO4940408A1 (es) | Composicion de aerosol farmaceutico | |
JO2381B1 (en) | Formulation containing anticholinergic drug for the treatment of chronic obstructive pulmonary disease | |
AR029523A1 (es) | Formulaciones farmaceuticas en solucion estable para inhaladores presurizados con medicion de dosis | |
CL2008002407A1 (es) | Forma de dosificacion oral que comprende al menos un agente activo de nicotina, al menos un material bioadhesivo capaz de formar un enlace de hidrogeno con el agente activo de nicotina, y al menos un agente de impacto sensorial que se libere rapidamente; y su uso para proporcionar alivio rapido de las ansias de nicotina (div. sol. 1825-04). | |
AR018410A1 (es) | Uso de una composicion para la manufactura de un medicamento que se usa para la prevencion o tratamiento de un estado agudo de asma y/o asma intermitentey/o episodios de asma cronico y metodo para la prevencion o tratamiento de un estado agudo de asma y/o asma intermitente y/o episodios de asma cron | |
NO990454L (no) | Aerosol-materiale | |
MX9704550A (es) | Formulaciones de medicamentos en aerosol. | |
DK0616525T3 (da) | Medikamenter | |
NO20012517D0 (no) | Farmasöytisk aerosolsammensetning inneholdende HFA 227 og HFA | |
ES2193186T3 (es) | Composiciones medicamentosas en aerosol para la utilizacion con gases propulsores sin cfc. | |
ES2126536A1 (es) | "preparado farmaceutico para administracion intranasal"y procedimiento para su produccion. | |
TNSN04148A1 (en) | Aerosol formulations for pulmonary administration of medicaments to produce a systemic effect | |
BR0107730A (pt) | Inalador aerosol | |
ES2134634T3 (es) | Composiciones farmaceuticas y dispositivos para su administracion. | |
BG107257A (en) | Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases | |
ECSP088732A (es) | Aerosoles dosificadores para la administración de preparaciones farmacéuticas | |
DE60318182D1 (de) | Aerosol-formulierungen mit estern von 3,17-dihydroxyöstratrien-derivaten zur pulmonalen abgabe |